Back to Capital World Investors Capital World Investors

TXGTXG
Showing 8 of 23 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in 10x Genomics Inc Class A

Capital World Investors holds 1.5M shares of TXG (10x Genomics Inc Class A), worth $57.2M as of 2026-Q2. The position was increased (+2.8% shares). TXG represents 0.0% of Capital World Investors's portfolio.

Current Value

$57.2M

Current Shares

1.5M

Total Value Change

+$39.3M

Total Shares Change

+699,731

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+2.8%
$57.2M0.0%$38.34
30
2026-Q1
Unchanged
1.5M
0.0%
$30.8M0.0%$22.62
0
2025-Q4
Unchanged
1.5M
0.0%
$23.7M0.0%$16.29
0
2025-Q3
Unchanged
1.5M
0.0%
$17M0.0%$11.34
0
2025-Q2
Unchanged
1.5M
0.0%
$16.8M0.0%$11.73
0
2025-Q1
Increased
1.5M
+83.1%
$12.7M0.0%$9.16
43
2024-Q4
Unchanged
793,300
0.0%
$11.4M0.0%$14.35
0
2024-Q3
Unchanged
793,300
0.0%
$17.9M0.0%$22.67
0

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used